Search Tag: RenalSense

ICU Management

2020 28 Jul

ABSTRACT Renal Replacement Therapy (RRT) is a complex treatment modality for a high-risk, critical care patient population with advanced AKI. While there are still no clear guidelines regarding the timing of initiation and termination of RRT, there is a growing body of evidence supporting the importance of urine monitoring and the clinical significance...Read more

ICU Management

2020 30 Jun

ABSTRACT This review discusses the importance of continuous, real-time monitoring of urine flow in critical care patients and its potential role in Acute Kidney Injury (AKI) and fluid management in a variety of clinical conditions.  Real-time, reliable monitoring of urine flow enables clinicians to detect early signs of kidney injury, and facilitates...Read more

ICU Management

2020 03 Jun

Incidence and risk factors for acute kidney injury (AKI) in COVID-19 patients Recent reports from China, Italy, and the US indicate that there is a 25-37% incidence of AKI among critically ill COVID-19 patients (Singh 2020, Hirsch et al. 2020). In a study of 5449 hospitalized COVID-19 patients, AKI was observed primarily in patients with respiratory...Read more

ICU Management

2020 23 Apr

RenalSense has started commercial sales of its Clarity RMSTM system in Europe in conjunction with its distribution partner Fresenius Medical Care (Bad Homburg). The Clarity RMS received CE Mark approval in August 2019. AKI occurs in over 55% of ICU patients, and is often associated with a high risk of chronic kidney disease, as well as increased...Read more